Epizyme Inc (EPZM)
Epizyme Inc (EPZM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98,336 | 168,215 | 139,482 | 86,671 | 226,664 |
| Marketable Securities | 78,454 | 205,391 | 241,605 | 153,633 | 49,775 |
| Receivables | 6,572 | 3,105 | 2,567 | 20,067 | 382 |
| Inventories | 3,216 | 10,461 | N/A | N/A | N/A |
| TOTAL | $206,043 | $405,093 | $399,177 | $272,535 | $285,804 |
| Non-Current Assets | |||||
| PPE Net | 1,545 | 2,152 | 2,219 | 2,057 | 2,527 |
| Intangibles | 42,849 | 47,002 | 0 | 0 | 0 |
| Other Non-Current Assets | 38,563 | 19,326 | 23,193 | 909 | 1,028 |
| TOTAL | $82,957 | $68,480 | $25,412 | $2,966 | $3,555 |
| Total Assets | $289,000 | $473,573 | $424,589 | $275,501 | $289,359 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,265 | 10,163 | 8,782 | 4,780 | 7,001 |
| Accrued Expenses | 30,777 | 28,572 | 22,565 | 19,700 | 17,549 |
| Other current liabilities | N/A | N/A | N/A | 53 | 4 |
| TOTAL | $45,196 | $43,400 | $34,386 | $37,833 | $24,664 |
| Non-Current Liabilities | |||||
| Long Term Debt | 216,461 | 215,670 | 23,309 | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 13,300 | N/A |
| Other Non-Current Liabilities | 36,081 | 29,606 | 31,951 | 853 | 515 |
| TOTAL | $264,492 | $245,276 | $59,066 | $4,659 | $29,324 |
| Total Liabilities | $309,688 | $288,676 | $93,452 | $42,492 | $53,988 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 164,482 | 101,785 | 100,771 | 79,207 | 69,440 |
| Common Shares | 11 | 10 | 10 | 8 | 7 |
| Retained earnings | -1,239,835 | -988,713 | -757,019 | -586,724 | -488,097 |
| Other shareholders' equity | 3 | 3 | 19 | -54 | -49 |
| TOTAL | $-20,688 | $184,897 | $331,137 | $233,009 | $235,371 |
| Total Liabilities And Equity | $289,000 | $473,573 | $424,589 | $275,501 | $289,359 |